Remove Investors Remove Mergers and Acquisitions Remove Private Equity
article thumbnail

What the new private sale process regime means for private equity investors

JD Supra: Mergers

The UK Takeover Panel (the Panel) has published a new framework for private sale processes. If you are a private equity investor considering potential P2P acquisitions after receiving initial soundings from management teams, then this new regime should be helpful in enabling early stage talks to happen in private.

article thumbnail

Antitrust scrutiny of private equity deals intensifies

JD Supra: Mergers

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. This is changing. By: Allen & Overy LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Private Equity Firms Select Investment Targets and Build Capital: Insights for Entrepreneurs

JD Supra: Mergers

What do private equity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? They covered the current private equity landscape, strategies for creating value, industry trends, various investment structures, and more.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Acquires CardioOne 

JD Supra: Mergers

WindRose Health Investors has announced its acquisition of CardioOne. CardioOne, founded in 2023 and based in Houston, is a management services partner and technology platform designed for independent cardiology practices. By: McGuireWoods LLP

article thumbnail

Private Equity Consolidation of Physician Practices Steady Despite Economic Conditions

JD Supra: Mergers

During the past 12 years, private equity (PE) firms have served as major investors in the U.S. health care market, participating in acquisitions and consolidations of physician practices across various specialties.

article thumbnail

Private Equity Interest in Lower Middle Market Acquisitions Remains Strong

Global Banking & Finance

Regarding mergers and acquisitions (M&A), private equity continues to show robust interest in acquiring lower middle market (LMM) companies. While large M&A transaction volume fell in the first half of 2024, the allure of LMM acquisitions remains high.

article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Acquires CardioOne

JD Supra: Mergers

WindRose Health Investors has announced the acquisition of CardioOne. CardioOne, founded in 2022 and based in Houston, is a physician enablement company that serves independent cardiologists. By: McGuireWoods LLP